Massive Bio has introduced a new feature on its Patient Connect app, integrating with the Oracle Cerner platform to simplify access to electronic health records (EHRs).
Both healthcare providers and patients will be able to utilise EHRs for enhanced cancer care and trial enrollment through this integration.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The launch supports Massive Bio’s commitment to the Centers for Medicare & Medicaid Services (CMS) to support healthcare interoperability across the US.
The Cerner application addresses the ongoing issue of fragmented medical data in oncology, which complicates patients’ ability to access complete medical histories and challenges hospitals in screening large patient populations for trial eligibility.
Along with Epic, Cerner serves around two-thirds of care providers and more than three-quarters of hospital capacity in the US.
Integration with this platform allows Massive Bio to extend its reach across a significant portion of the US healthcare system.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe application offers a dual solution. Patients can link their My Cerner Chart and Massive Bio profile, enabling easy retrieval of comprehensive medical records.
This facilitates patient engagement and ensures data is ready for analysis via Massive Bio’s AI-driven prescreening hubs.
For healthcare providers, the app introduces a bulk data retrieval capability. Cancer centres and hospitals can securely process multiple consented patients’ records simultaneously.
Massive Bio co-founder and CEO Selin Kurnaz said: “Our mission is to ensure that every cancer patient has access to the best possible treatment options, and that starts with breaking down data silos.
“By integrating with a leading EHR provider like Cerner, we are empowering patients to control their data and providing hospitals with the tools they need to accelerate life-saving research.”
